Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed objectives and criteria for a clinical trial involving ruxolitinib, while adding new identifiers and collaborators related to the study.SummaryDifference41%
- Check47 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 20, 2024.SummaryDifference0.7%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check90 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check105 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.